会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • Sulfonamide derivatives
    • 磺酰胺衍生物
    • EP0469901A1
    • 1992-02-05
    • EP91307061.1
    • 1991-08-01
    • TAISHO PHARMACEUTICAL CO. LTDNIPPON SUISAN KAISHA, LTD.
    • Sato, MasakazuKawashima, YutakaGoto, JunChiba, YoshiyukiSatake, MikioIwata, ChuzoImanishi, Takeshi
    • C07C323/49C07C317/28C07C317/44C07C323/20C07D213/71A61K31/18
    • C07C317/44C07C317/28C07C323/49C07C323/62C07D213/71
    • Sulfonamide derivative, useful as blood platelet aggregation inhibitors, have the formula:

      in which A is a naphthyl group, a pyridyl group, a phenyl group, a phenyl group substituted by 1 to 5 substituents selected from halogen atoms, alkyl groups having 1 to 4 carbon atoms, alkoxy groups having 1 to 4 carbon atoms, nitro groups and acetamido groups, or an alkyl group having 1 to 20 carbon atoms; B is an alkylene group having 1 to 3 carbon atoms, a group -OCH₂- or a group -CH=CH-; X and Y are the same or different, and each is a hydrogen or fluorine atom; R is a carboxy group, an alkyoxycarbonyl group having 2 to 5 carbon atoms, a hydroxymethyl group or a group of the formula
      (in which R¹ is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms; R² is a hydrogen atom, a hydroxyl group, an alkyl group having 1 to 3 carbon atoms, a carboxymethyl group or an alkoycarbonylmethyl group having 3 to 6 carbon atoms); m is 0, 1 or 2; n is 0,1,2 or 3; or salts thereof.
      This invention also provided intermediates for the preparation of the sulfonamide, which intermediates are thiophenols of the formula:

      (in which R, X and Y are as defined above).
    • 可用作血小板聚集抑制剂的磺酰胺衍生物具有下式:其中A是萘基,吡啶基,苯基,被1至5个选自卤素原子的取代基取代的苯基,具有1至4个碳原子的烷基 碳原子,具有1至4个碳原子的烷氧基,硝基和乙酰氨基,或具有1至20个碳原子的烷基; B是具有1-3个碳原子的亚烷基,基团-OCH 2 - 或基团-CH = CH-; X和Y相同或不同,并且各自是氢或氟原子; R为羧基,具有2至5个碳原子的烷氧基羰基,羟甲基或下式基团(其中R 1为氢原子或具有1至3个碳原子的烷基; R 2为氢原子, 羟基,碳原子数为1〜3的烷基,羧甲基或碳原子数为3〜6的烷基羰甲基)。 m是0,1或2; n是0,1,2或3; 或其盐。 本发明还提供了用于制备磺酰胺的中间体,其中间体是下式的苯硫酚:(其中R,X和Y如上所定义)。
    • 4. 发明公开
    • 2-Azetidinone derivatives
    • 2-氮杂环丁酮衍生物
    • EP0365364A3
    • 1991-12-11
    • EP89310857.1
    • 1989-10-20
    • TAISHO PHARMACEUTICAL CO. LTD
    • Kawashima, YutakaSato, MasakazuKawase, MasahiroWatanabe, YoshiakiHatayama, Katsuo
    • C07D205/10C07D401/12A61K31/395
    • C07D401/12C07D205/10Y10S514/822
    • 2-Azetizinone derivatives, useful as blood platelet aggregation inhibiting agents, are those of the formula:
      in which R 1 is a halogen atom a C 1 -C 4 alkyl group, a C 1 -C 4 alkoxy group or an alkoxycarbonyl group in which the alkoxy group is a C 1 -C 4 alkoxy group; R 2 is a group of the formula:
      (in which R 3 and R 4 are the same or different and each is a hydrogen atom, a C 1 -C 5 alkenyl group, a phenyl group or a benzyl group), a group of the formula:
      (in which R 5 is a hydrogen atom, a phenyl group substituted by a halogen atom or a C 1 -C 4 alkoxy group, a phenyl group, a C 1 -C 4 alkyl group or a pyridyl group), a group of the formula:
      (in which R 6 is a hydrogen atom, a Ci-C 4 alkyl group or a benzyl group and R 7 is a hydrogen atom or a C 1 -C 4 alkyl group), a group of the formula:
      (in which R 8 and R 9 are the same or different and each is a hydrogen atom or C 1 -C 4 alkyl group), a pyrrolidinyl group or a tetrahydroazepinyl group; and n is an integer of from 2 to 10; and salts thereof.
    • 用作血小板聚集抑制剂的2-氮杂氮酮衍生物是下式的那些:其中R1是卤素原子,C1-C4烷基,C1-C4烷氧基或烷氧基羰基,其中烷氧基是 C1-C4烷氧基; R 2是下式的基团:(其中R 3和R 4相同或不同并且各自是氢原子,C 1 -C 5烯基,苯基或苄基),式 其中R5是氢原子,被卤素原子或C1-C4烷氧基取代的苯基,苯基,C1-C4烷基或吡啶基),下式基团(其中R6是 氢原子,C 1 -C 4烷基或苄基,并且R 7为氢原子或C 1 -C 4烷基),下式的基团(其中R 8和R 9相同或不同并且各自为 氢原子或C1-C4烷基),吡咯烷基或四氢氮杂基; 并且n是2至10的整数; 及其盐。
    • 5. 发明公开
    • 2-Azetidinone derivatives
    • 2 Azetidinonderivate。
    • EP0365364A2
    • 1990-04-25
    • EP89310857.1
    • 1989-10-20
    • TAISHO PHARMACEUTICAL CO. LTD
    • Kawashima, YutakaSato, MasakazuKawase, MasahiroWatanabe, YoshiakiHatayama, Katsuo
    • C07D205/10C07D401/12A61K31/395
    • C07D401/12C07D205/10Y10S514/822
    • 2-Azetizinone derivatives, useful as blood platelet aggregation inhibiting agents, are those of the formula:


      in which R 1 is a halogen atom a C 1 -C 4 alkyl group, a C 1 -C 4 alkoxy group or an alkoxycarbonyl group in which the alkoxy group is a C 1 -C 4 alkoxy group; R 2 is a group of the formula:

      (in which R 3 and R 4 are the same or different and each is a hydrogen atom, a C 1 -C 5 alkenyl group, a phenyl group or a benzyl group), a group of the formula:

      (in which R 5 is a hydrogen atom, a phenyl group substituted by a halogen atom or a C 1 -C 4 alkoxy group, a phenyl group, a C 1 -C 4 alkyl group or a pyridyl group), a group of the formula:

      (in which R 6 is a hydrogen atom, a Ci-C 4 alkyl group or a benzyl group and R 7 is a hydrogen atom or a C 1 -C 4 alkyl group), a group of the formula:

      (in which R 8 and R 9 are the same or different and each is a hydrogen atom or C 1 -C 4 alkyl group), a pyrrolidinyl group or a tetrahydroazepinyl group; and n is an integer of from 2 to 10; and salts thereof.
    • 可用作血小板聚集抑制剂的2-氮杂酮酮衍生物是下式的那些:其中R 1是卤素原子,C 1 -C 4烷基,C 1 -C 4烷氧基或烷氧羰基 其中烷氧基是C1-C4烷氧基; R 2是下式的基团:其中R 3和R 4相同或不同,各自为氢原子,C1-C5烯基,苯基或 苄基),下式的基团:其中R 5为氢原子,被卤素原子或C 1 -C 4烷氧基取代的苯基,苯基,C 1 -C 4烷基 基或吡啶基),式:CHEM(其中R 6为氢原子,C 1 -C 4烷基或苄基,R 7为氢原子或C 1 -C4烷基),下式的基团:其中R 8和R 9相同或不同,各自为氢原子或C 1 -C 4烷基),吡咯烷基或 四氢氮杂基; n为2〜10的整数, 及其盐。